Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 16, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences Inc
| -14.25K |
$146.69 | -$2,090,332.50 | -27.54% | 37.49K |
Aug 15
| |||||||
Fate Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 22
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 20
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Neurocrine Biosciences Inc
| 8.96K |
$72.22 | -$1,192,327.07 | +20.93% | 51.74K |
Jan 2
|
Scheduled
| ||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 10
| |||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Fate Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 17
| |||||||
Neurocrine Biosciences Inc
| 3.33K |
$57.07 | -$339,221.49 | +8.43% | 42.78K |
May 1
| |||||||
Neurocrine Biosciences Inc
| 5.44K |
$58.87 | -$571,318.98 | +15.98% | 39.46K |
Apr 19 - Apr 21
| |||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Fate Therapeutics Inc
| 8.65K |
—
|
—
| +322.64% | 11.33K |
Jun 9
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Neurocrine Biosciences Inc
| 9.27K |
$50.80 | -$885,166.13 | +37.46% | 34.02K |
Apr 1
|
Scheduled
| ||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Fate Therapeutics Inc
| 2.68K |
—
|
—
|
∞
| 2.68K |
Jun 2
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Fate Therapeutics Inc
|
0
|
—
|
—
|
—
| 146.82K |
Mar 30
| |||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 25
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Fate Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
May 1
| |||||||
Fate Therapeutics Inc
| 28.46K |
$1.37 | $38,991.57 |
∞
| 28.46K |
Mar 30
| |||||||
Regulus Therapeutics Inc.
| 225.94K |
—
|
—
| +137.23% | 390.58K |
Feb 3
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 24
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 10
| |||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 22
| |||||||
Regulus Therapeutics Inc.
| 92.89K |
$1.08 | $100,320.12 | +151.45% | 154.22K |
May 7
| |||||||
Regulus Therapeutics Inc.
| 92.89K |
$1.08 | $100,320.12 | +151.45% | 154.22K |
May 7
| |||||||
Fate Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
May 3
| |||||||
Regulus Therapeutics Inc.
| 23.26K |
—
|
—
| +41.23% | 79.67K |
Nov 12
| |||||||
Dare Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 10
| |||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.